Foundations for Polaris-CD
Development
The hallmark of an effective outcomes management system is
a strong foundation in theory and research. When assessment
scales developed for some other purpose are pressed into service
as an outcomes measure, the data may be useful to evaluate
program effectiveness but are not clinically actionable. They
have little or no value in enhancing treatment because they
provide no information useful to the clinician working with
a specific patient. Polaris-CD is the best example of an
outcomes management system whose measures were designed explicitly
to support clinical decision making.
Polaris-CD was created in response to research that has
repeatedly documented high relapse rates following treatment,
high probability of re-entry into treatment and high incidence
of dropout. Ineffective treatment leads to enormous human
suffering and medical costs.
An effective program must address key questions for each
patient:
• What services are most cost-effective for this patient?
• Is his/her treatment “working”; i.e.,
is the patient’s progress satisfactory?
• Is this person at high risk for relapse, and, if so,
how can he/she be helped to maintain recovery?
Polaris-CD helps treatment programs to answer these key
questions, and to improve outcomes through patient-treatment
matching, concurrent monitoring, and assessment of risk for
dropout and relapse.
Patient-Treatment Matching
There have been numerous attempts to match substance abuse
patients to treatment programs. In view of the wide variability
among programs and patients, it seems reasonable to pose the
question raised by the Institute of Medicine after its review
of alcoholism research: "which kinds of individuals...
are likely to respond to what kinds of treatments by achieving
which kinds of goals" (10).
The findings from studies that have attempted to improve
outcomes by matching patients to programs were equivocal,
due to methodological limitations (16). Project Match, an
elegantly designed and well-funded study, was initiated by
NIAAA to provide a definitive test of the matching hypothesis
for alcoholism. The national, multi-site, randomized clinical
trial involved over 1700 patients and addressed the methodological
limitations of prior studies. Its conclusions were encouraging
in relation to treatment effectiveness (patients experienced
gains in each of the three modalities studied) but discouraging
in relation to matching: of the ten matching variables studied,
only one (psychiatric severity) was useful in matching outpatients
to treatments (21).
In contrast, a five year NIDA-sponsored study of matching
conducted by PsyberMetrics staff in collaboration with the
University of Pennsylvania's Center for Study of Addiction
found that outcomes could be significantly improved by matching
patients to services, rather than to programs (18). The researchers
discovered that numerous limitations on treatment referral
made it impractical to attempt to match patients to programs.
Nearly two thirds (62%) of the 186 patients in the initial
study cohort could not be referred to the program considered
optimal by their evaluator: limitations in insurance or HMO
coverage precluded placement; the preferred program did not
have a treatment slot or bed available; the patient insisted
upon referral to the program most convenient in relation to
their home or work; or the patient viewed the program negatively
due to prior experience or that of a friend/family member.
Even if it were technically feasible, the value of patient-program
matching would be limited due to these non-clinical factors
in referral.
Switching their focus, the research team developed and tested
a procedure for matching patients to services (not programs),
on the basis of their composite scores on the family, psychiatric,
and employment subscales of the Addiction Severity Index (ASI).
Threshold scores were established for each subscale, and the
experimental group patients were provided with special services
in each area where their scores exceeded the threshold. For
example, those with elevated scores on the Family subscale
received treatment focused upon family issues. Control group
patients received standard care in the same programs.
Patients matched to services using this procedure achieved
impressive outcomes in relation to unmatched controls. They
were more likely to complete treatment (93% vs. 81%). Outcomes
reported on the follow-up ASI (six months post-treatment)
were uniformly more positive for the matched group (e.g.,
35% of the control group patients had re-entered treatment,
versus 24% of the matched group).
In summary, patients who received treatment directed towards
their specific problems experienced significantly more positive
outcomes than similar patients, treated in the same programs
by the same therapists, who were not matched to services (18).
The "matching" procedure developed under this research
has been incorporated into Polaris-CD.
Concurrent Monitoring
Following the initial (intake) patient assessment, Polaris-CD
provides for monitoring of patient progress during treatment.
Monitoring concurrent with treatment provides clinically actionable
data to providers; helps to identify persons who should be
monitored post-treatment (i.e., high risk cases); and introduces
monitoring as a routine component of the treatment process
to improve compliance with post-discharge monitoring procedures.
PsyberMetrics co-founder Kenneth Howard, Ph.D., and his team
at Northwestern University pioneered the use of concurrent
monitoring as a tool for continuous quality improvement. This
work has shown that data collected concurrently with treatment
has direct clinical value and can also be analyzed to determine
the likelihood that the current treatment will be successful
(8).
Finally, concurrent monitoring promotes an organizational
culture that values outcomes management. Providing therapists
with actionable information helps to secure their full cooperation
with a measurement system, which in turn is essential to the
establishment of an organizational "culture of measurement"
(4,3)
Assessment of Risk for Dropout and Relapse
Polaris-CD includes more than a dozen questions which
prior research have found to be predictive of dropout or relapse.
This information can be used clinically to assess the need
for interventions (e.g., Motivation Enhancement Therapy, or
Relapse Prevention) designed to reduce negative outcomes.
The predictive validity research demonstrates the effectiveness
of the system in identifying high risk patients.
|